AVENTYL HYDROCHLORIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Aventyl Hydrochloride, and when can generic versions of Aventyl Hydrochloride launch?
Aventyl Hydrochloride is a drug marketed by Lilly and is included in one NDA.
The generic ingredient in AVENTYL HYDROCHLORIDE is nortriptyline hydrochloride. There are twelve drug master file entries for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the nortriptyline hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Aventyl Hydrochloride
A generic version of AVENTYL HYDROCHLORIDE was approved as nortriptyline hydrochloride by DR REDDYS LABS SA on March 30th, 1992.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for AVENTYL HYDROCHLORIDE?
- What are the global sales for AVENTYL HYDROCHLORIDE?
- What is Average Wholesale Price for AVENTYL HYDROCHLORIDE?
Summary for AVENTYL HYDROCHLORIDE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 92 |
Clinical Trials: | 1 |
Patent Applications: | 1,473 |
DailyMed Link: | AVENTYL HYDROCHLORIDE at DailyMed |
Recent Clinical Trials for AVENTYL HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Central Michigan University | N/A |
Sheppard Pratt Health System | N/A |
US Patents and Regulatory Information for AVENTYL HYDROCHLORIDE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lilly | AVENTYL HYDROCHLORIDE | nortriptyline hydrochloride | CAPSULE;ORAL | 014684-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Lilly | AVENTYL HYDROCHLORIDE | nortriptyline hydrochloride | CAPSULE;ORAL | 014684-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for AVENTYL HYDROCHLORIDE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Lilly | AVENTYL HYDROCHLORIDE | nortriptyline hydrochloride | CAPSULE;ORAL | 014684-001 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
Lilly | AVENTYL HYDROCHLORIDE | nortriptyline hydrochloride | CAPSULE;ORAL | 014684-002 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for AVENTYL HYDROCHLORIDE
See the table below for patents covering AVENTYL HYDROCHLORIDE around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Germany | 1468341 | ⤷ Sign Up | |
Netherlands | 6408512 | ⤷ Sign Up | |
Brazil | 6461109 | ⤷ Sign Up | |
Switzerland | 494730 | Verfahren zur Herstellung von Dibenzocyclopentenen (Dibenzo cycloheptenes) | ⤷ Sign Up |
Belgium | 650988 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |